Mostrando 5 resultados de: 5
Filtros aplicados
Publisher
Annals of the New York Academy of Sciences(1)
Genes(1)
Genetics and Molecular Biology(1)
International Journal of Molecular Sciences(1)
Pharmacogenomics in Latin America: Challenges and Opportunities(1)
Cancer pharmacogenomic studies in Latin America
Book PartAbstract: For more than 50 years it has been proven that the genetic differences among people contribute to inPalabras claves:Cáncer, Latin America, pharmacogenetics, Pharmacogenomics, SNPsAutores:Andrés López-Cortés, Redal M.A., Santiago Xavier GuerreroFuentes:googlescopusMonitoring of DNA damage in individuals exposed to petroleum hydrocarbons in Ecuador
Conference ObjectAbstract: Currently, it is known that several chemical agents used or generated by the oil industry are classiPalabras claves:Cáncer, Chromosomal alterations test, Chromosomes, comet assay, CYP 1A1, DNA, genotoxicity, Hydrocarbons, Malformations, MSH2Autores:Andrés López-Cortés, Arévalo M., Cesar Paz-y-Miño, María-Eugenia SánchezFuentes:googlescopusRelationship of an hRAD54 gene polymorphism (2290 C/T) in an ecuadorian population with chronic myelogenous leukemia
ArticleAbstract: The hRAD54 gene is a key member of the RAD52 epistasis group involved in repair of double-strand brePalabras claves:2290 C/T polymorphism, ALL, Cáncer, CML, hRAD54, LeukemiaAutores:Alejandro Cabrera-Andrade, Andrés López-Cortés, Castro B., Cesar Paz-y-Miño, Eugenia Sánchez M., María José G. MuñozFuentes:scopusState of art of cancer pharmacogenomics in Latin American populations
ReviewAbstract: Over the past decades, several studies have shown that tumor-related somatic and germline alterationPalabras claves:Cáncer, Latin America, pharmacogenetics, Pharmacogenomics, Precision Medicine, Single nucleotide polymorphismAutores:Alvarado A.T., Andrés López-Cortés, Quiñones L.A., Redal M.A., Santiago Xavier GuerreroFuentes:googlescopusTcga pan-cancer genomic analysis of alternative lengthening of telomeres (Alt) related genes
ArticleAbstract: Telomere maintenance mechanisms (TMM) are used by cancer cells to avoid apoptosis, 85–90% reactivatePalabras claves:ALT, Cáncer, IN SILICO, TelomeresAutores:Ana Karina Zambrano, Andrés López-Cortés, Andy Pérez-Villa, Cesar Paz-y-Miño, Isaac Armendáriz-Castillo, Jennyfer M. García-Cárdenas, P. Guevara-Ramírez, Paola E. Leone, Santiago Xavier Guerrero, Verónica YumicebaFuentes:scopus